Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The new Climax Professor of Clinical Therapeutics will join the Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences at the Medical Sciences Division and St Hilda’s College in February 2019 to lead Oxford’s answer to a key global challenge – how to determine quickly which potential new therapies have the properties to become important medicines.

Professor Duncan Richards will establish a new Centre for Clinical Therapeutics based at the Botnar Research Centre. The Centre, under his leadership, will work with a diverse range of Oxford biomedical researchers and more widely with the pharmaceutical, biotechnology and diagnostics industries, in order to drive promising new drug treatments through decision-making in early phase clinical trials.

Read more (NDORMS website)

Similar stories

Population-scale study highlights ongoing risk of COVID-19 in some cancer patients despite vaccination

COVID-19 vaccination is effective in most cancer patients, but the level of protection against COVID-19 infection, hospitalisation and death offered by the vaccine is less than in the general population and vaccine effectiveness wanes more quickly.

New reporting guidelines developed to improve AI in healthcare settings

New reporting guidelines, jointly published in Nature Medicine and the BMJ by Oxford researchers, will ensure that early studies on using Artificial Intelligence (AI) to treat real patients will give researchers the information needed to develop AI systems safely and effectively.

Major boost for Oxford’s mission to counter future pandemic threats

The Moh Family Foundation has given a substantial gift to support the work of Oxford University’s Pandemic Sciences Institute, greatly strengthening its ability to identify and counter future pandemic threats and ensure equitable access to treatments and vaccines around the world.

Three NHSBT research units launch at University of Oxford

The NIHR has awarded three new Blood and Transplant Research Units (BTRUs) to the University of Oxford.

Fourth COVID-19 vaccine dose provides stronger immunity boost than third dose, shows UK study

COVID-19 vaccines given as fourth doses in the UK offer excellent boosting immunity protection, according to the latest results from a nationwide NIHR-supported study.